Exact Mass: 255.2021

Exact Mass Matches: 255.2021

Found 140 metabolites which its exact mass value is equals to given mass value 255.2021, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Diphenhydramine

N-(2-(Diphenylmethoxy)ethyl)-N,N-dimethylamine

C17H21NO (255.1623)


Diphenhydramine is a histamine H1 antagonist used as an antiemetic, antitussive, for dermatoses and pruritus, for hypersensitivity reactions, as a hypnotic, an antiparkinson, and as an ingredient in common cold preparations. It has some undesired antimuscarinic and sedative effects. -- Pubchem; Pseudoephedrine is a phenethylamine, and an isomer of ephedrine. Pseudoephedrine is the International Nonproprietary Name (INN) of the (1S,2S)- diastereomer of ephedrine (which has 1R,2S- configuration). Other names are (+)-pseudoephedrine and D-pseudoephedrine (Reynolds, 1989). The enantiomer (-)-(1R,2R)-Pseudoephedrine has fewer side-effects, fewer central nervous system (CNS) stimulatory effects, does not reduce to d-methamphetamine, yet retains its efficacy as a decongestant.[citation needed] However, the patent holder for (-)-Pseudoephedrine (Pfizer/Warner-Lambert) has not yet sought or received government approval for its sale to the public.(US Patent 6,495,529); Treatment for urinary incontinence is an unlabeled use for these medications. Unlabeled use means doctors can use the medication to treat a condition other than that for which it was first approved by the U.S. Food and Drug Administration (FDA). These medications are approved by the FDA for the treatment of nasal congestion caused by colds or allergies. However it has also been successful in treating stress incontinence by increasing the pressure (tension) exerted by the muscles of the bladder neck and the urethra, which helps retain the urine within the bladder. Despite being one of the oldest antihistamines on the market, it is by and large the most effective antihistamine available, either by prescription or over-the-counter, and has been shown to exceed the effectiveness of even the latest prescription drugs. Consequently, it is frequently used when an allergic reaction requires fast, effective reversal of the (often dangerous) effects of a massive histamine release. However, it is not always the drug of choice for treating allergies. Like many other first generation antihistamines, is also a potent anticholinergic agent. This leads to profound drowsiness as a very common side-effect, along with the possibilities of motor impairment (ataxia), dry mouth and throat, flushed skin, rapid or irregular heartbeat (tachycardia), blurred vision at near point due to lack of accommodation (cycloplegia), abnormal sensitivity to bright light (photophobia), pupil dilatation, urinary retention, constipation, difficulty concentrating, short-term memory loss, visual disturbances, hallucinations, confusion, erectile dysfunction, and delirium. -- Wikipedia;. A histamine H1 antagonist used as an antiemetic, antitussive, for dermatoses and pruritus, for hypersensitivity reactions, as a hypnotic, an antiparkinson, and as an ingredient in common cold preparations. It has some undesired antimuscarinic and sedative effects. -- Pubchem; Pseudoephedrine is a phenethylamine, and an isomer of ephedrine. Pseudoephedrine is the International Nonproprietary Name (INN) of the (1S,2S)- diastereomer of ephedrine (which has 1R,2S- configuration). Other names are (+)-pseudoephedrine and D-pseudoephedrine (Reynolds, 1989). The enantiomer (-)-(1R,2R)-Pseudoephedrine has fewer side-effects, fewer central nervous system (CNS) stimulatory effects, does not reduce to d-methamphetamine, yet retains its efficacy as a decongestant.[citation needed] However, the patent holder for (-)-Pseudoephedrine (Pfizer/Warner-Lambert) has not yet sought or received government approval for its sale to the public.(US Patent 6,495,529); Treatment for urinary incontinence is an unlabeled use for these medications. Unlabeled use means doctors can use the medication to treat a condition other than that for which it was first approved by the U.S. Food and Drug Administration (FDA). These medications are approved by the FDA for the treatment of nasal congestion caused by colds or allergies. However it has also been successful in treating stress incontinence by increasing the pressure (tension) exerted by the muscles of the bladder neck and the urethra, which helps retain the urine within the bladder.; Despite being one of the oldest antihistamines on the market, it is by and large the most effective antihistamine available, either by prescription or over-the-counter, and has been shown to exceed the effectiveness of even the latest prescription drugs. Consequently, it is frequently used when an allergic reaction requires fast, effective reversal of the (often dangerous) effects of a massive histamine release. However, it is not always the drug of choice for treating allergies. Like many other first generation antihistamines, is also a potent anticholinergic agent. This leads to profound drowsiness as a very common side-effect, along with the possibilities of motor impairment (ataxia), dry mouth and throat, flushed skin, rapid or irregular heartbeat (tachycardia), blurred vision at near point due to lack of accommodation (cycloplegia), abnormal sensitivity to bright light (photophobia), pupil dilatation, urinary retention, constipation, difficulty concentrating, short-term memory loss, visual disturbances, hallucinations, confusion, erectile dysfunction, and delirium. -- Wikipedia [HMDB] D - Dermatologicals > D04 - Antipruritics, incl. antihistamines, anesthetics, etc. > D04A - Antipruritics, incl. antihistamines, anesthetics, etc. > D04AA - Antihistamines for topical use R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AA - Aminoalkyl ethers D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics CONFIDENCE standard compound; EAWAG_UCHEM_ID 3352 D018926 - Anti-Allergic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Diphenhydramine is a first-generation histamine H1-receptor antagonist with anti-cholinergic effect. Diphenhydramine hydrochloride can across the ovine blood-brain barrier (BBB) [1][2][3].

   

Tripelennamine

N-benzyl-N-[2-(dimethylamino)ethyl]pyridin-2-amine

C16H21N3 (255.1735)


Tripelennamine is only found in individuals that have used or taken this drug. It is a histamine H1 antagonist with low sedative action but frequent gastrointestinal irritation. It is used to treat asthma; HAY fever; urticaria; and rhinitis; and also in veterinary applications. Tripelennamine is administered by various routes, including topically. [PubChem]Tripelennamine binds to the histamine H1 receptor. This blocks the action of endogenous histamine, which subsequently leads to temporary relief of the negative symptoms brought on by histamine. D - Dermatologicals > D04 - Antipruritics, incl. antihistamines, anesthetics, etc. > D04A - Antipruritics, incl. antihistamines, anesthetics, etc. > D04AA - Antihistamines for topical use R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AC - Substituted ethylene diamines D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D018926 - Anti-Allergic Agents

   

Pyrrolysine

N~6~-{[(2s,3s)-3-Methyl-3,4-Dihydro-2h-Pyrrol-2-Yl]carbonyl}-L-Lysine

C12H21N3O3 (255.1583)


A N(6)-acyl-L-lysine having a (2R,3R)-3-methyl-3,4-dihydro-2H-pyrrol-2-ylcarboxy group at the N(6)-position.

   

Phenyltoloxamine

N,N-Dimethyl-2-(alpha-phenyl-O-tolyloxy)ethylamine

C17H21NO (255.1623)


C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Phenyltoloxamine is a first-generation ethanolamine H1-antihistamine.

   

Atomoxetine

N-METHYL-GAMMA-(2-METHYLPHENOXY)BENZENEPROPANAMINE HYDROCHLORIDE

C17H21NO (255.1623)


Atomoxetine is the first non-stimulant drug approved for the treatment of attention-deficit hyperactivity disorder (ADHD). It is sold in the form of the hydrochloride salt of atomoxetine. This chemical is manufactured and marketed under the brand name Strattera; by Eli Lilly and Company and as a generic Attentin by Torrent Pharmaceuticals. There is currently no generic available within the United States due to patent restrictions. [Wikipedia] N - Nervous system > N06 - Psychoanaleptics > N06B - Psychostimulants, agents used for adhd and nootropics > N06BA - Centrally acting sympathomimetics D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018759 - Adrenergic Uptake Inhibitors C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C185721 - Norepinephrine Reuptake Inhibitor C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents D049990 - Membrane Transport Modulators

   

N-Demethyl orphenadrine

methyl({2-[(2-methylphenyl)(phenyl)methoxy]ethyl})amine

C17H21NO (255.1623)


N-Demethyl orphenadrine is a metabolite of orphenadrine. Orphenadrine is an anticholinergic drug of the ethanolamine antihistamine class with prominent CNS and peripheral actions used to treat painful muscle spasms, other similar conditions, as well as the treatment of some aspects of Parkinsons Disease. It is closely related to diphenhydramine. Therefore, it is related to other drugs used for Parkinsons like benztropine and trihexyphenidyl, and it is also structurally related to nefopam, which is a centrally-acting yet non-opioid analgesic. (Wikipedia) C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists

   

Dimemorfan

4,17-dimethyl-17-azatetracyclo[7.5.3.0^{1,10}.0^{2,7}]heptadeca-2(7),3,5-triene

C18H25N (255.1987)


   
   

Despropylspiroxamine

Despropylspiroxamine

C15H29NO2 (255.2198)


   

N-Decanoyl-DL-homoserine lactone

N-Decanoyl-DL-homoserine lactone

C14H25NO3 (255.1834)


   

Dehydrodarlingianin|Dehydrodarlingianine

Dehydrodarlingianin|Dehydrodarlingianine

C17H21NO (255.1623)


   

2-hept-2-enyl-3-methyl-1H-quinolin-4-one

2-hept-2-enyl-3-methyl-1H-quinolin-4-one

C17H21NO (255.1623)


   

2-Methylpropylamide-(2E,6E,8Z)-2,6,8-Tridecatriene-10,12-diynoic acid|trideca-2t,6t,8c-trien-10,12-diynoic acid (2-methylbutyl)amide

2-Methylpropylamide-(2E,6E,8Z)-2,6,8-Tridecatriene-10,12-diynoic acid|trideca-2t,6t,8c-trien-10,12-diynoic acid (2-methylbutyl)amide

C17H21NO (255.1623)


   

N-isobutyl-4-hexanoyl-4-hydroxypyrrolidin-1-one|pipercycliamide

N-isobutyl-4-hexanoyl-4-hydroxypyrrolidin-1-one|pipercycliamide

C14H25NO3 (255.1834)


   

longipenamide B|N-isobutyl-syn-6,9-dihydroxy-2E,7E-decadienamide

longipenamide B|N-isobutyl-syn-6,9-dihydroxy-2E,7E-decadienamide

C14H25NO3 (255.1834)


   

longipenamide A|N-isobutyl-syn-8,9-dihydroxy-2E,6Z-decadienamide

longipenamide A|N-isobutyl-syn-8,9-dihydroxy-2E,6Z-decadienamide

C14H25NO3 (255.1834)


   

1-(Dimethylaminomethyl)-5-isopropyl-3,8-dimethylazulene|1.4-Dimethyl-3-dimethylaminomethyl-7-isopropyl-azulen|3-(N,N-dimethylamino)methylguaiazulene|N,N-dimethylamino-3-guaiazulenylmethane

1-(Dimethylaminomethyl)-5-isopropyl-3,8-dimethylazulene|1.4-Dimethyl-3-dimethylaminomethyl-7-isopropyl-azulen|3-(N,N-dimethylamino)methylguaiazulene|N,N-dimethylamino-3-guaiazulenylmethane

C18H25N (255.1987)


   

3-hydroxy-7-isobutyl-6-methyl-hexahydro-pyrazino[1,2-b]pyridazine-5,8-dione

3-hydroxy-7-isobutyl-6-methyl-hexahydro-pyrazino[1,2-b]pyridazine-5,8-dione

C12H21N3O3 (255.1583)


   

PRESKIMMIANINE

PRESKIMMIANINE

C17H21NO (255.1623)


   

Atomoxetine

Atomoxetine

C17H21NO (255.1623)


N - Nervous system > N06 - Psychoanaleptics > N06B - Psychostimulants, agents used for adhd and nootropics > N06BA - Centrally acting sympathomimetics D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018759 - Adrenergic Uptake Inhibitors C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C185721 - Norepinephrine Reuptake Inhibitor C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents D049990 - Membrane Transport Modulators CONFIDENCE standard compound; EAWAG_UCHEM_ID 2846

   

diphenhydramine

diphenhydramine

C17H21NO (255.1623)


D - Dermatologicals > D04 - Antipruritics, incl. antihistamines, anesthetics, etc. > D04A - Antipruritics, incl. antihistamines, anesthetics, etc. > D04AA - Antihistamines for topical use R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AA - Aminoalkyl ethers D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D018926 - Anti-Allergic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE standard compound; INTERNAL_ID 2671 CONFIDENCE standard compound; INTERNAL_ID 8588 CONFIDENCE standard compound; INTERNAL_ID 4116 Diphenhydramine is a first-generation histamine H1-receptor antagonist with anti-cholinergic effect. Diphenhydramine hydrochloride can across the ovine blood-brain barrier (BBB) [1][2][3].

   

tripelennamine

tripelennamine

C16H21N3 (255.1735)


D - Dermatologicals > D04 - Antipruritics, incl. antihistamines, anesthetics, etc. > D04A - Antipruritics, incl. antihistamines, anesthetics, etc. > D04AA - Antihistamines for topical use R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AC - Substituted ethylene diamines D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D018926 - Anti-Allergic Agents

   

SPI_256.2273_14.6

SPI_256.2273_14.6

C15H29NO2 (255.2198)


CONFIDENCE Probable structure via diagnostic evidence, tentative identification (Level 2b); INTERNAL_ID 1811

   

Atomexetine

Atomexetine

C17H21NO (255.1623)


   

C10-homoserine lactone

N-Decanoyl-DL-homoserine lactone

C14H25NO3 (255.1834)


CONFIDENCE standard compound; INTERNAL_ID 204

   

Diphenydramine

diphenhydramine

C17H21NO (255.1623)


Diphenhydramine is a first-generation histamine H1-receptor antagonist with anti-cholinergic effect. Diphenhydramine hydrochloride can across the ovine blood-brain barrier (BBB) [1][2][3].

   

Tofenacin

N-Desmethylorphenadrine

C17H21NO (255.1623)


C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists

   

Dinorpropoxyphenecarbinol

Dinorpropoxyphenecarbinol

C17H21NO (255.1623)


   

(E)-1-(but-3-yn-1-yl)-4-(pent-2-en-4-yn-1-yl)octahydro-2H-quinolizine

(E)-1-(but-3-yn-1-yl)-4-(pent-2-en-4-yn-1-yl)octahydro-2H-quinolizine

C18H25N (255.1987)


   

Phenyltoloxamine

Phenyltoloxamine

C17H21NO (255.1623)


C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist

   

N-decanoyl-L-Homoserine lactone

N-[3S)-tetrahydro-2-oxo-3-furanyl]-decanamide

C14H25NO3 (255.1834)


   

C10:0-HSL

N-decanoyl-homoserine lactone

C14H25NO3 (255.1834)


   

Albanitrile E

17-Hydroxyheptadeca-6,8,10-triynenitrile

C17H21NO (255.1623)


   

TERT-BUTYL 2-(TERT-BUTYL)-4-OXOPIPERIDINE-1-CARBOXYLATE

TERT-BUTYL 2-(TERT-BUTYL)-4-OXOPIPERIDINE-1-CARBOXYLATE

C14H25NO3 (255.1834)


   

(S)-4-(tert-Butoxycarbonylamino)-2,6-dimethyl-1-hepten-3-one

(S)-4-(tert-Butoxycarbonylamino)-2,6-dimethyl-1-hepten-3-one

C14H25NO3 (255.1834)


   

N,N-Dimethylformamide dicyclohexyl acetal

Methanamine,1,1-bis(cyclohexyloxy)-N,N-dimethyl-

C15H29NO2 (255.2198)


   

(1r,2s)-2-(isopropylamino)-1,2-diphenylethanol

(1r,2s)-2-(isopropylamino)-1,2-diphenylethanol

C17H21NO (255.1623)


   

N-BOC-CIS-2,6-DIETHYL-4-PIPERIDONE

N-BOC-CIS-2,6-DIETHYL-4-PIPERIDONE

C14H25NO3 (255.1834)


   

(2S)-2-(Dibenzylamino)-1-propanol

(2S)-2-(Dibenzylamino)-1-propanol

C17H21NO (255.1623)


   

3-(diethylcarbamoyl)-1,2,2-trimethyl-cyclopentane-1-carboxylic acid

3-(diethylcarbamoyl)-1,2,2-trimethyl-cyclopentane-1-carboxylic acid

C14H25NO3 (255.1834)


   

(1s,2r)-2-(isopropylamino)-1,2-diphenylethanol

(1s,2r)-2-(isopropylamino)-1,2-diphenylethanol

C17H21NO (255.1623)


   

(2R)-2-Amino-3-methyl-1,1-diphenyl-1-butanol

(2R)-2-Amino-3-methyl-1,1-diphenyl-1-butanol

C17H21NO (255.1623)


   

4-(trans-4-Pentylcyclohexyl)benzonitrile

4-(trans-4-Pentylcyclohexyl)benzonitrile

C18H25N (255.1987)


   

Dimemorfan

Dimemorfan

C18H25N (255.1987)


R - Respiratory system > R05 - Cough and cold preparations > R05D - Cough suppressants, excl. combinations with expectorants > R05DA - Opium alkaloids and derivatives D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids C78273 - Agent Affecting Respiratory System > C66917 - Antitussive Agent C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent D019141 - Respiratory System Agents > D000996 - Antitussive Agents D002491 - Central Nervous System Agents

   

N-[2-(Dimethylamino)phenyl]-N,N-dimethyl-1,2-benzenediamine

N-[2-(Dimethylamino)phenyl]-N,N-dimethyl-1,2-benzenediamine

C16H21N3 (255.1735)


   

tert-Butyl 4-((1R,2S)-2-(hydroxymethyl)cyclopropyl)piperidine-1-carboxylate

tert-Butyl 4-((1R,2S)-2-(hydroxymethyl)cyclopropyl)piperidine-1-carboxylate

C14H25NO3 (255.1834)


   

tert-butyl 2-oxa-9-azaspiro[5.5]undecane-9-carboxylate

tert-butyl 2-oxa-9-azaspiro[5.5]undecane-9-carboxylate

C14H25NO3 (255.1834)


   

9-Oxa-2-azaspiro[5.5]undecan-9-carboxylic acid tert-butyl ester

9-Oxa-2-azaspiro[5.5]undecan-9-carboxylic acid tert-butyl ester

C14H25NO3 (255.1834)


   

tetradecyl isothiocyanate

tetradecyl isothiocyanate

C15H29NS (255.2021)


   

10-n-boc-amino-dec-1-ene

10-n-boc-amino-dec-1-ene

C15H29NO2 (255.2198)


   

2-(2-tert-butyl-5-methylphenoxy)aniline

2-(2-tert-butyl-5-methylphenoxy)aniline

C17H21NO (255.1623)


   

3-benzyloxy-4-butylaniline

3-benzyloxy-4-butylaniline

C17H21NO (255.1623)


   

4-(3,9-diazaspiro[5.5]undecan-3-yl)benzonitrile

4-(3,9-diazaspiro[5.5]undecan-3-yl)benzonitrile

C16H21N3 (255.1735)


   

1-(4-butylphenyl)-2,5-dimethylpyrrole-3-carbaldehyde

1-(4-butylphenyl)-2,5-dimethylpyrrole-3-carbaldehyde

C17H21NO (255.1623)


   

hexamethylguanidinium trimethyldifluoro siliconate

hexamethylguanidinium trimethyldifluoro siliconate

C10H27F2N3Si (255.1942)


   

(1R,2S)-(+)-2-AMINOCYCLOHEX-3-ENECARBOXYLICACIDHYDROCHLORIDE

(1R,2S)-(+)-2-AMINOCYCLOHEX-3-ENECARBOXYLICACIDHYDROCHLORIDE

C17H21NO (255.1623)


   

(1-Furan-2-yl-ethyl)-(3-methyl-1-phenyl-but-3-enyl)-amine

(1-Furan-2-yl-ethyl)-(3-methyl-1-phenyl-but-3-enyl)-amine

C17H21NO (255.1623)


   

benzyl-hexyl-dimethylazanium,chloride

benzyl-hexyl-dimethylazanium,chloride

C15H26ClN (255.1754)


   

4-Methoxy-alpha-methyl-N-(phenylmethyl)benzeneethanamine

4-Methoxy-alpha-methyl-N-(phenylmethyl)benzeneethanamine

C17H21NO (255.1623)


   

tert-butyl 2,6-diethyl-4-oxopiperidine-1-carboxylate

tert-butyl 2,6-diethyl-4-oxopiperidine-1-carboxylate

C14H25NO3 (255.1834)


   

(S)-1-BOC-3-(3-METHYLBUTANOYL)PYRROLIDINE

(S)-1-BOC-3-(3-METHYLBUTANOYL)PYRROLIDINE

C14H25NO3 (255.1834)


   

Heptaverine

Heptaverine

C18H25N (255.1987)


   

Bindschedlers green leuco base

1,4-Benzenediamine,N4-[4-(dimethylamino)phenyl]-N1,N1-dimethyl-

C16H21N3 (255.1735)


   

4-BOC-1-OXA-4-AZASPIRO[5.5]UNDECANE

4-BOC-1-OXA-4-AZASPIRO[5.5]UNDECANE

C14H25NO3 (255.1834)


   

6-methylheptyl prop-2-enoate,prop-2-enamide

6-methylheptyl prop-2-enoate,prop-2-enamide

C14H25NO3 (255.1834)


   

3,5-Diethyl-1,2-dihydro-1-phenyl-2-propylpyridine

3,5-Diethyl-1,2-dihydro-1-phenyl-2-propylpyridine

C18H25N (255.1987)


   

Furan-2-ylmethyl-(3-methyl-1-p-tolyl-but-3-enyl)-amine

Furan-2-ylmethyl-(3-methyl-1-p-tolyl-but-3-enyl)-amine

C17H21NO (255.1623)


   

Volazocine

Volazocine

C18H25N (255.1987)


   

TERT-BUTYL 4-(PYRROLIDIN-3-YL)PIPERAZINE-1-CARBOXYLATE

TERT-BUTYL 4-(PYRROLIDIN-3-YL)PIPERAZINE-1-CARBOXYLATE

C13H25N3O2 (255.1947)


   

2-Methyl-2-propanyl 4,4-dimethyl-1-oxa-7-azaspiro[4.4]nonane-7-ca rboxylate

2-Methyl-2-propanyl 4,4-dimethyl-1-oxa-7-azaspiro[4.4]nonane-7-ca rboxylate

C14H25NO3 (255.1834)


   

3-(4-TERT-BUTYL-PHENOXY)BENZYLAMINE

3-(4-TERT-BUTYL-PHENOXY)BENZYLAMINE

C17H21NO (255.1623)


   
   

tert-butyl 4-(3-aminoazetidin-1-yl)piperidine-1-carboxylate

tert-butyl 4-(3-aminoazetidin-1-yl)piperidine-1-carboxylate

C13H25N3O2 (255.1947)


   

(S)-(-)-2-Amino-3-methyl-1,1-diphenyl-1-butanol

(S)-(-)-2-Amino-3-methyl-1,1-diphenyl-1-butanol

C17H21NO (255.1623)


   

2-[benzyl(methyl)amino]-1-phenylpropan-1-ol

2-[benzyl(methyl)amino]-1-phenylpropan-1-ol

C17H21NO (255.1623)


   

N-Boc-3-Cyclohexylaminopropionaldehyde

N-Boc-3-Cyclohexylaminopropionaldehyde

C14H25NO3 (255.1834)


   

1-Propanol,3-(dibenzyl amino)-(7CI,8CI)

1-Propanol,3-(dibenzyl amino)-(7CI,8CI)

C17H21NO (255.1623)


   

3-Oxa-9-azaspiro[5.5]undecan-9-carboxylic acid tert-butyl ester

3-Oxa-9-azaspiro[5.5]undecan-9-carboxylic acid tert-butyl ester

C14H25NO3 (255.1834)


   

(S)-TERT-BUTYL 2-((1R,2S)-1-HYDROXY-2-METHYLBUT-3-EN-1-YL)PYRROLIDINE-1-CARBOXYLATE

(S)-TERT-BUTYL 2-((1R,2S)-1-HYDROXY-2-METHYLBUT-3-EN-1-YL)PYRROLIDINE-1-CARBOXYLATE

C14H25NO3 (255.1834)


   

Hexahydro-1,3,5-tripropionyl-S-triazine

Hexahydro-1,3,5-tripropionyl-S-triazine

C12H21N3O3 (255.1583)


   

4-(TRANS-4-N-PENTYLCYCLOHEXYL)BENZONITRILE

4-(TRANS-4-N-PENTYLCYCLOHEXYL)BENZONITRILE

C18H25N (255.1987)


   

2-methyl-1-[(4-methylphenyl)methyl]-3,4,5,6,7,8-hexahydro-1H-isoquinoline

2-methyl-1-[(4-methylphenyl)methyl]-3,4,5,6,7,8-hexahydro-1H-isoquinoline

C18H25N (255.1987)


   

2-Pentyloxy-5-phenylaniline

2-Pentyloxy-5-phenylaniline

C17H21NO (255.1623)


   

Deriglidole

Deriglidole

C16H21N3 (255.1735)


   

Oxifentorex

Oxifentorex

C17H21NO (255.1623)


   

1-[bis(phenylmethyl)amino]-2-Propanol

1-[bis(phenylmethyl)amino]-2-Propanol

C17H21NO (255.1623)


   

1-(4-Methoxyphenyl)-2-benzylaminopropane

1-(4-Methoxyphenyl)-2-benzylaminopropane

C17H21NO (255.1623)


   

1-BENZYL-3-(CYCLOHEX-1-EN-1-YL)PYRROLIDIN-2-ONE

1-BENZYL-3-(CYCLOHEX-1-EN-1-YL)PYRROLIDIN-2-ONE

C17H21NO (255.1623)


   

(2S)-2-amino-3-methyl-1,1-diphenylbutan-1-ol (en)Benzenemethanol, .α.-(1-amino-2-methylpropyl)-.α.-phenyl- (en)

(2S)-2-amino-3-methyl-1,1-diphenylbutan-1-ol (en)Benzenemethanol, .α.-(1-amino-2-methylpropyl)-.α.-phenyl- (en)

C17H21NO (255.1623)


   

tert-butyl 2-(hydroxymethyl)-7-azaspiro[3.5]nonane-7-carboxylate

tert-butyl 2-(hydroxymethyl)-7-azaspiro[3.5]nonane-7-carboxylate

C14H25NO3 (255.1834)


   

ERYTHRO-2-(ISOPROPYLAMINO)-1 2-DIPHENYL

ERYTHRO-2-(ISOPROPYLAMINO)-1 2-DIPHENYL

C17H21NO (255.1623)


   

1-octyl-3-MethyliMidazoliuM thiocyanate

1-octyl-3-MethyliMidazoliuM thiocyanate

C13H25N3S (255.1769)


   

FMOC-L-SS-HOMO-VAL-OH

FMOC-L-SS-HOMO-VAL-OH

C17H21NO (255.1623)


   

tert-butyl N-(1-piperidin-4-ylazetidin-3-yl)carbamate

tert-butyl N-(1-piperidin-4-ylazetidin-3-yl)carbamate

C13H25N3O2 (255.1947)


   

tert-Butyl (1-(piperidin-3-yl)azetidin-3-yl)carbamate

tert-Butyl (1-(piperidin-3-yl)azetidin-3-yl)carbamate

C13H25N3O2 (255.1947)


   

tert-butyl N-[(1-pyrrolidin-3-ylazetidin-3-yl)methyl]carbamate

tert-butyl N-[(1-pyrrolidin-3-ylazetidin-3-yl)methyl]carbamate

C13H25N3O2 (255.1947)


   

8-Methyl-2-(3-methylbutyl)-1,2,4-triazaspiro[4.5]decane-3-thione

8-Methyl-2-(3-methylbutyl)-1,2,4-triazaspiro[4.5]decane-3-thione

C13H25N3S (255.1769)


   

N-[(3s)-2-Oxotetrahydrofuran-3-Yl]decanamide

N-[(3s)-2-Oxotetrahydrofuran-3-Yl]decanamide

C14H25NO3 (255.1834)


   

Hexadecanoate

Hexadecanoate

C16H31O2- (255.2324)


A long-chain fatty acid anion that is the conjugate base of hexadecanoic acid (palmitic acid); major species at pH 7.3.

   

(2S)-2-azaniumyl-6-({[(2R,3R)-3-methyl-3,4-dihydro-2H-pyrrol-2-yl]carbonyl}amino)hexanoate

(2S)-2-azaniumyl-6-({[(2R,3R)-3-methyl-3,4-dihydro-2H-pyrrol-2-yl]carbonyl}amino)hexanoate

C12H21N3O3 (255.1583)


   

14-Methylpentadecanoate

14-Methylpentadecanoate

C16H31O2- (255.2324)


A methyl-branched fatty acid anion that is the conjugate base of 14-methylpentadecanoic acid resulting from the deprotonation of the carboxy group; major microspecies at pH 7.3.

   

8a-Butyl-3,3,6,6-tetramethyltetrahydro-1,8-dioxa-4a-azanaphthalene

8a-Butyl-3,3,6,6-tetramethyltetrahydro-1,8-dioxa-4a-azanaphthalene

C15H29NO2 (255.2198)


   

[2-[1-(Dimethylamino)ethyl]phenyl]-phenylmethanol

[2-[1-(Dimethylamino)ethyl]phenyl]-phenylmethanol

C17H21NO (255.1623)


   

(1R,9R,10S)-4,17-Dimethyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene

(1R,9R,10S)-4,17-Dimethyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene

C18H25N (255.1987)


   

(Z)-Delta-oxomycolate

(Z)-Delta-oxomycolate

C14H23O4- (255.1596)


   

Propanamide, N-(1-cyclohexylethyl)-N-(trimethylsilyl)-

Propanamide, N-(1-cyclohexylethyl)-N-(trimethylsilyl)-

C14H29NOSi (255.2018)


   

1,3-Dimethyl-5-trimethylsilyloxy-2-azabicyclo[4.4.0]decane

1,3-Dimethyl-5-trimethylsilyloxy-2-azabicyclo[4.4.0]decane

C14H29NOSi (255.2018)


   

N-[(4E,8E)-1,3-dihydroxydodeca-4,8-dien-2-yl]acetamide

N-[(4E,8E)-1,3-dihydroxydodeca-4,8-dien-2-yl]acetamide

C14H25NO3 (255.1834)


   

(Z)-N-(2-hydroxyethyl)tridec-9-enamide

(Z)-N-(2-hydroxyethyl)tridec-9-enamide

C15H29NO2 (255.2198)


   

N~6~-{[(2s,3s)-3-Methyl-3,4-Dihydro-2h-Pyrrol-2-Yl]carbonyl}-L-Lysine

N~6~-{[(2s,3s)-3-Methyl-3,4-Dihydro-2h-Pyrrol-2-Yl]carbonyl}-L-Lysine

C12H21N3O3 (255.1583)


   

fatty acid anion 16:0

fatty acid anion 16:0

C16H31O2 (255.2324)


Any saturated fatty acid anion containing 16 carbons. Formed by deprotonation of the carboxylic acid moiety. Major species at pH 7.3.

   
   

1-(1-methylpyrrolidin-2-yl)-6-phenylhexa-3,5-dien-2-one

1-(1-methylpyrrolidin-2-yl)-6-phenylhexa-3,5-dien-2-one

C17H21NO (255.1623)


   

(5s)-5-hexanoyl-5-hydroxy-1-(2-methylpropyl)pyrrolidin-2-one

(5s)-5-hexanoyl-5-hydroxy-1-(2-methylpropyl)pyrrolidin-2-one

C14H25NO3 (255.1834)


   

5-hexanoyl-5-hydroxy-1-(2-methylpropyl)pyrrolidin-2-one

5-hexanoyl-5-hydroxy-1-(2-methylpropyl)pyrrolidin-2-one

C14H25NO3 (255.1834)


   

1-[6-(2-hydroxybutyl)-1-methyl-3,6-dihydro-2h-pyridin-2-yl]pentan-2-ol

1-[6-(2-hydroxybutyl)-1-methyl-3,6-dihydro-2h-pyridin-2-yl]pentan-2-ol

C15H29NO2 (255.2198)


   

(8r,9r)-8,9-dihydroxy-n-(2-methylpropyl)deca-2,6-dienimidic acid

(8r,9r)-8,9-dihydroxy-n-(2-methylpropyl)deca-2,6-dienimidic acid

C14H25NO3 (255.1834)


   

(2z)-1-[(1r,5s)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl]-3-phenylprop-2-en-1-one

(2z)-1-[(1r,5s)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl]-3-phenylprop-2-en-1-one

C17H21NO (255.1623)


   

(6z,8e)-2,5-dihydroxy-n-(2-methylpropyl)deca-6,8-dienimidic acid

(6z,8e)-2,5-dihydroxy-n-(2-methylpropyl)deca-6,8-dienimidic acid

C14H25NO3 (255.1834)


   

n-(2-methylpropyl)trideca-2,6,8-trien-10,12-diynimidic acid

n-(2-methylpropyl)trideca-2,6,8-trien-10,12-diynimidic acid

C17H21NO (255.1623)


   

(2e,6z,8r,9r)-8,9-dihydroxy-n-(2-methylpropyl)deca-2,6-dienimidic acid

(2e,6z,8r,9r)-8,9-dihydroxy-n-(2-methylpropyl)deca-2,6-dienimidic acid

C14H25NO3 (255.1834)


   

11,12-dihydroxytetradeca-5,8-dienimidic acid

11,12-dihydroxytetradeca-5,8-dienimidic acid

C14H25NO3 (255.1834)


   

(5z,8z)-11,12-dihydroxytetradeca-5,8-dienimidic acid

(5z,8z)-11,12-dihydroxytetradeca-5,8-dienimidic acid

C14H25NO3 (255.1834)


   

(3e,5e)-1-[(2r)-1-methylpyrrolidin-2-yl]-6-phenylhexa-3,5-dien-2-one

(3e,5e)-1-[(2r)-1-methylpyrrolidin-2-yl]-6-phenylhexa-3,5-dien-2-one

C17H21NO (255.1623)


   

2-[(2e)-hept-2-en-1-yl]-3-methyl-1h-quinolin-4-one

2-[(2e)-hept-2-en-1-yl]-3-methyl-1h-quinolin-4-one

C17H21NO (255.1623)


   

(2e,7e)-6,9-dihydroxy-n-(2-methylpropyl)deca-2,7-dienimidic acid

(2e,7e)-6,9-dihydroxy-n-(2-methylpropyl)deca-2,7-dienimidic acid

C14H25NO3 (255.1834)


   

(2e,6e,8z)-n-(2-methylpropyl)trideca-2,6,8-trien-10,12-diynimidic acid

(2e,6e,8z)-n-(2-methylpropyl)trideca-2,6,8-trien-10,12-diynimidic acid

C17H21NO (255.1623)


   

(6r,9r)-6,9-dihydroxy-n-(2-methylpropyl)deca-2,7-dienimidic acid

(6r,9r)-6,9-dihydroxy-n-(2-methylpropyl)deca-2,7-dienimidic acid

C14H25NO3 (255.1834)


   

n-[(3s)-2-oxooxolan-3-yl]decanimidic acid

n-[(3s)-2-oxooxolan-3-yl]decanimidic acid

C14H25NO3 (255.1834)


   

(2s)-1-[(2s,6r)-6-[(2s)-2-hydroxybutyl]-1-methyl-3,6-dihydro-2h-pyridin-2-yl]pentan-2-ol

(2s)-1-[(2s,6r)-6-[(2s)-2-hydroxybutyl]-1-methyl-3,6-dihydro-2h-pyridin-2-yl]pentan-2-ol

C15H29NO2 (255.2198)


   

(2e,6z)-8,9-dihydroxy-n-(2-methylpropyl)deca-2,6-dienimidic acid

(2e,6z)-8,9-dihydroxy-n-(2-methylpropyl)deca-2,6-dienimidic acid

C14H25NO3 (255.1834)


   

n-(2-oxooxolan-3-yl)decanimidic acid

n-(2-oxooxolan-3-yl)decanimidic acid

C14H25NO3 (255.1834)


   

(2e,6r,7e,9r)-6,9-dihydroxy-n-(2-methylpropyl)deca-2,7-dienimidic acid

(2e,6r,7e,9r)-6,9-dihydroxy-n-(2-methylpropyl)deca-2,7-dienimidic acid

C14H25NO3 (255.1834)


   

(2r)-1-[(2s,6r)-6-[(2r)-2-hydroxybutyl]-1-methyl-3,6-dihydro-2h-pyridin-2-yl]pentan-2-ol

(2r)-1-[(2s,6r)-6-[(2r)-2-hydroxybutyl]-1-methyl-3,6-dihydro-2h-pyridin-2-yl]pentan-2-ol

C15H29NO2 (255.2198)


   

hexahydro-1h-pyrrolizin-1-ylmethyl 2-hydroxy-3-methylpentanoate

hexahydro-1h-pyrrolizin-1-ylmethyl 2-hydroxy-3-methylpentanoate

C14H25NO3 (255.1834)


   

4,7,8-trimethyl-3-(3-methylbut-2-en-1-yl)quinolin-2-ol

4,7,8-trimethyl-3-(3-methylbut-2-en-1-yl)quinolin-2-ol

C17H21NO (255.1623)


   

2-(hept-2-en-1-yl)-3-methyl-1h-quinolin-4-one

2-(hept-2-en-1-yl)-3-methyl-1h-quinolin-4-one

C17H21NO (255.1623)


   

(1s,7as)-hexahydro-1h-pyrrolizin-1-ylmethyl (2r,3r)-2-hydroxy-3-methylpentanoate

(1s,7as)-hexahydro-1h-pyrrolizin-1-ylmethyl (2r,3r)-2-hydroxy-3-methylpentanoate

C14H25NO3 (255.1834)